Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 4
2015 4
2016 11
2017 3
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
Measles.
Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL. Rota PA, et al. Among authors: thompson km. Nat Rev Dis Primers. 2016 Jul 14;2:16049. doi: 10.1038/nrdp.2016.49. Nat Rev Dis Primers. 2016. PMID: 27411684 Review.
Measles is an infectious disease in humans caused by the measles virus (MeV). Before the introduction of an effective measles vaccine, virtually everyone experienced measles during childhood. ...
Measles is an infectious disease in humans caused by the measles virus (MeV). Before the introduction of an effective measl
Modeling and Managing the Risks of Measles and Rubella: A Global Perspective Part II.
Thompson KM. Thompson KM. Risk Anal. 2017 Jun;37(6):1041-1051. doi: 10.1111/risa.12823. Epub 2017 May 4. Risk Anal. 2017. PMID: 28471528
Measles and rubella continue to circulate globally. Complementing Part I of the special issue, this introduction provides a contrast between other global eradication initiatives and the experience with measles and rubella eradication to date. This intr
Measles and rubella continue to circulate globally. Complementing Part I of the special issue, this introduction provides a co
What will it take to end fatalities from measles?
Thompson KM. Thompson KM. Lancet Glob Health. 2019 Apr;7(4):e394-e395. doi: 10.1016/S2214-109X(19)30050-6. Epub 2019 Feb 21. Lancet Glob Health. 2019. PMID: 30797736 Free article. No abstract available.
Evolution and Use of Dynamic Transmission Models for Measles and Rubella Risk and Policy Analysis.
Thompson KM. Thompson KM. Risk Anal. 2016 Jul;36(7):1383-403. doi: 10.1111/risa.12637. Epub 2016 Jun 9. Risk Anal. 2016. PMID: 27277138 Review.
This review finds significant underreporting of measles and rubella infections and widespread recognition of the importance of achieving and maintaining high population immunity to stop and prevent measles and rubella transmission. The significantly lo …
This review finds significant underreporting of measles and rubella infections and widespread recognition of the importance of …
Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
Thompson KM, Badizadegan ND. Thompson KM, et al. Risk Anal. 2017 Jun;37(6):1109-1131. doi: 10.1111/risa.12831. Epub 2017 May 31. Risk Anal. 2017. PMID: 28561947
With endemic measles and rubella transmission interrupted in the region of the Americas, all five other regions of the World Health Organization (WHO) targeting the elimination of measles transmission by 2020, and increasing adoption of rubella vaccine …
With endemic measles and rubella transmission interrupted in the region of the Americas, all five other regions of the World H …
Systematic Review of Health Economic Analyses of Measles and Rubella Immunization Interventions.
Thompson KM, Odahowski CL. Thompson KM, et al. Risk Anal. 2016 Jul;36(7):1297-314. doi: 10.1111/risa.12331. Epub 2014 Dec 24. Risk Anal. 2016. PMID: 25545778 Review.
The 67 analyses we included demonstrate the large economic benefits associated with preventing measles and rubella infections using vaccines and the benefit of combining measles and rubella antigens into a formulation that saves the costs associated wi …
The 67 analyses we included demonstrate the large economic benefits associated with preventing measles and rubella infections …
Modeling and Managing the Risks of Measles and Rubella: A Global Perspective, Part I.
Thompson KM, Cochi SL. Thompson KM, et al. Risk Anal. 2016 Jul;36(7):1288-96. doi: 10.1111/risa.12655. Risk Anal. 2016. PMID: 27424287
Achieving the GVAP measles and rubella goals will require significant immunization efforts and associated financial investments and political commitments. Planning and budgeting for these efforts can benefit from learning some important lessons from the Global Polio …
Achieving the GVAP measles and rubella goals will require significant immunization efforts and associated financial investment …
The Costs and Valuation of Health Impacts of Measles and Rubella Risk Management Policies.
Thompson KM, Odahowski CL. Thompson KM, et al. Risk Anal. 2016 Jul;36(7):1357-82. doi: 10.1111/risa.12459. Epub 2015 Aug 5. Risk Anal. 2016. PMID: 26249331
To support estimates of the economic benefits of investments in measles and/or rubella elimination or control, we characterize the probabilities of various sequelae of measles and rubella infections and vaccine adverse events, the DALY inputs for healt …
To support estimates of the economic benefits of investments in measles and/or rubella elimination or control, we characterize …
Systematic Review of Measles and Rubella Serology Studies.
Thompson KM, Odahowski CL. Thompson KM, et al. Risk Anal. 2016 Jul;36(7):1459-86. doi: 10.1111/risa.12430. Epub 2015 Jun 16. Risk Anal. 2016. PMID: 26077609 Review.
Cross-sectional serological studies provide data about the age- and sex-specific immunity levels for individuals in the studied population, and these data can provide a point of comparison for the results of transmission models. In the context of developing an integrated model fo …
Cross-sectional serological studies provide data about the age- and sex-specific immunity levels for individuals in the studied population, …
Research priorities for global measles and rubella control and eradication.
Goodson JL, Chu SY, Rota PA, Moss WJ, Featherstone DA, Vijayaraghavan M, Thompson KM, Martin R, Reef S, Strebel PM. Goodson JL, et al. Among authors: thompson km. Vaccine. 2012 Jul 6;30(32):4709-16. doi: 10.1016/j.vaccine.2012.04.058. Epub 2012 Apr 28. Vaccine. 2012. PMID: 22549089 Free article.
In 2010, an expert advisory panel convened by the World Health Organization to assess the feasibility of measles eradication concluded that (1) measles can and should be eradicated, (2) eradication by 2020 is feasible if measurable progress is made toward existing 2 …
In 2010, an expert advisory panel convened by the World Health Organization to assess the feasibility of measles eradication conclude …
17 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page